Contents hide 1 Non-Small Cell Lung Cancer 2 Inflammatory Myofibroblastic tumors 3 Dosage Modifications Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. Non-Small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors are anaplastic lymphoma kinase (ALK)- or ROS1-positive 250 mg PO BID Continue until disease progression or unacceptable toxicity Inflammatory Myofibroblastic tumors Indicated for unresectable, recurrent, or … Continue reading Kayzoni (Crizotinib)